Invesco’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $643K | Sell |
244,507
-23,843
| -9% | -$56.1K | ﹤0.01% | 3051 |
|
|
2025
Q4 | $513K | Buy |
268,350
+76,530
| +40% | +$181K | ﹤0.01% | 3187 |
|
|
2025
Q3 | $426K | Buy |
191,820
+36,803
| +24% | +$88.3K | ﹤0.01% | 3296 |
|
|
2025
Q2 | $222K | Buy |
155,017
+15,531
| +11% | +$22.6K | ﹤0.01% | 3485 |
|
|
2025
Q1 | $223K | Buy |
139,486
+70,293
| +102% | +$210K | ﹤0.01% | 3471 |
|
|
2024
Q4 | $249K | Buy |
69,193
+4,647
| +7% | +$23.1K | ﹤0.01% | 3468 |
|
|
2024
Q3 | $368K | Sell |
64,546
-953
| -1% | -$5.74K | ﹤0.01% | 3349 |
|
|
2024
Q2 | $303K | Buy |
65,499
+26,963
| +70% | +$161K | ﹤0.01% | 3497 |
|
|
2024
Q1 | $315K | Sell |
38,536
-653,546
| -94% | -$5.07M | ﹤0.01% | 3508 |
|
|
2023
Q4 | $3.91M | Buy |
692,082
+635,691
| +1,127% | +$1.45M | ﹤0.01% | 2355 |
|
|
2023
Q3 | $105K | Buy |
56,391
+481
| +0.9% | +$1.47K | ﹤0.01% | 3709 |
|
|
2023
Q2 | $154K | Sell |
55,910
-13,549
| -20% | -$43.5K | ﹤0.01% | 3662 |
|
|
2023
Q1 | $218K | Buy |
69,459
+53,233
| +328% | +$313K | ﹤0.01% | 3607 |
|
|
2022
Q4 | $95.7K | Sell |
16,226
-30
| -0.2% | -$249 | ﹤0.01% | 3833 |
|
|
2022
Q3 | $142K | Buy |
16,256
+2,401
| +17% | +$24.9K | ﹤0.01% | 3767 |
|
|
2022
Q2 | $105K | Sell |
13,855
-124,557
| -90% | -$1.1M | ﹤0.01% | 3877 |
|
|
2022
Q1 | $3.36M | Sell |
138,412
-325,790
| -70% | -$7.91M | ﹤0.01% | 2568 |
|
|
2021
Q4 | $14.9M | Sell |
464,202
-6,321
| -1% | -$250K | ﹤0.01% | 1747 |
|
|
2021
Q3 | $21M | Buy |
470,523
+1,128
| +0.2% | +$48.3K | 0.01% | 1536 |
|
|
2021
Q2 | $17.8M | Sell |
469,395
-140,324
| -23% | -$5.03M | ﹤0.01% | 1695 |
|
|
2021
Q1 | $22.6M | Buy |
609,719
+309,177
| +103% | +$12.3M | 0.01% | 1455 |
|
|
2020
Q4 | $9.96M | Buy |
+300,542
| New | +$8.72M | ﹤0.01% | 1816 |
|
Other funds holding CCCC
RCM
BCLSI
LCM
VCM
SCM
WA
